T-helper I versus T-helper 2 lymphocyte immunodysregulation is the central factor in genesis of Burkitt lymphoma: Hypothesis

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Lubega, Joseph ^a  

^a Bunny Hill Primary Care Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34249810681     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-10     Document Type: Article

References (43)

1. Burkitt DP: Epidemiology of Burkitt's lymphoma. Proc R Soc Med 1971, 64(9):909-10.
2. Stiller CA, Parkin DM: International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol 1990, 4:303-24.
3. Morrow RH, Kisuule A, Pike MC, Smith PG: Burkitt's lymphoma in the Mengo Districts of Uganda: epidemiologic features and their relationship to malaria. J Natl Cancer Inst 1976, 56(3):479-83.
4. O'Connor GT: Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor. Am J Med 1970, 48:279-85.
5. Epeldegui M, Hung YP, McQuay A, Ambinder RF, Martinez-Maza O: Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 2007, 44(5):934-42.
6. Rickinson AB, Kieff E: Epstein-Barr virus. In Fields Virology Edited by: Fields BN, Knipe DM, Howley PM. Philadelphia: Lippincott-Raven; 1996:2397-2446.
7. Young LS, Dawson CW, Eliopoulos AG: The expression and function of Epstein-Barr virus encoded latent genes. J Clin Pathol: Mol Palhol 2000, 53:238-247.
8. Pajic A, Polack A, Staege MS, Spitkovsky D, Baier B, Bornkamm GW, Laux G: Expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch. Journal of General Virology 2001, 82:3051 -3055.
9. Group I, International Agency for Research on Cancer (IARC): Summaries & Evaluations. Epstein-Barr Virus 1997, 70:47.
10. Schmauz R, Mugerwa JW, Wright DH: The distribution of nonBurkitt, non-Hodgkin's lymphomas in Uganda in relation to malarial endemicity. Int. J Cancer 45(4):650-3. 1990 Apr 15;
11. Moss D: Epstein-Barr virus and malaria in relation to Burkitt's lymphoma in Papua New Guinea. P N G Med J 1986, 29(1):41-3.
12. Morrow RH Jr: Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma. IARC Sci Publ 1985:177-86.
13. Geser A, Brubaker G, Draper CC: Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol 1989, 129:740-52.
14. Gunapala DE, Facer CA, Davidson R, Weir WR: In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. J Defective T-cell control Parasital Res 1990, 76(6):531-5.
15. Kataaha PK, Facer CA, Holborow EJ: Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus. Clin Exp Immunol 1984, 56:371-6.
16. Rochford R, Cannon MJ, Moormann AM: Endemic Burkitt's lymphoma: a polymicrobial disease? Not Rev Microbiol 2005, 3:182-7.
17. Cohen JI: Epstein-Barr virus infection. N Engl J Med 2000, 343:481-92.
18. Ambinder RF: Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Int J Cancer 92(5):687-91. 2001 Jun I;
19. Rabkin CS. Yellin F: Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type I. AIDS 1994, 8(8):1025-49.
20. Pintado V, Gil A, Lavilla P, Lopez-Dupla M, Villar A, Gamallo C, Garcia-Rubio B. Valencia E: Lymphomas in the acquired human immunodeficiency syndrome. Clinical, histological, immunological, and developmental study of 26 patients. Ann Oncol 1997, 8(10):987-94.
21. Spina M, Tirelli U, Zagonel V, Gloghini A, Volpe R, Babare R, Abbruzzese L, Talamini R, Vaccher E, Carbone A: Burkitt lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer 82(4):766-74. 1998 Feb 15;
22. Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, Willson E, Brynes R, Parker J, Rasheed S: Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991, 68(11):2466-72.
23. Serraino D, Franceschi S: Kaposi's sarcoma and non-Hodgkin's lymphomas in children and adolescents with AIDS. AIDS 1996. 10(6):643-7.
24. Pintado V, Gil A, Lavilla P, Lopez-Dupla M, Villar A, Gamallo C, Garcia-Rubio B, Valencia E: Lymphomas in the acquired human immunodeficiency syndrome. Clinical, histological, immunological, and developmental study of 26 patients. Ann Oncol 1997, 8(10):987-94.
25. Olweny CL, Katongole-Mbidde E, Otim D, Lwanga SK, Magrath IT, Ziegler JL: Long-term experience with Burkitt's lymphoma in Uganda. Int J Cancer 26(3):261-6. 1980 Sep 15;
26. Lucioni M, Capello D, Riboni R, Ippoliti G, Campana C, Bandiera L, Arcaini L, Rossi D, Cerri M, Dionigi P, Lazzarino M, Magrini U, Vigano M, Gaidano G, Paulli M: B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution. Transplantation 82(8): 1013-23. 2006 Oct 27;
27. Webber SA, Naftel DC, Fricker FJ, Olesnevich P, Blume ED, Addonizio L, Kirklin JK, Canter CE: The Pediatric Heart Transplant Study. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. The Lancet 367(9506):233-239.
28. Romagnani S, Del Prete G, Manetti R, et al.: Role of THI/TH2 cytokines in HIV infection. Immunol Rev 1994, 140:73-92.
29. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80(5):1289-98. 1992 Sep I;
30. Chintu C, Athale UH, Patil PS: Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child 1995, 73(2):100-4. discussion 104-5.
31. Chitsike I, Siziya S: Seroprevalence of human immunodeficiency virus type I infection in childhood malignancy in Zimbabwe. Cent AfrJ Med 1998, 44(10):242-5.
32. Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulaiteye S, Appleby P, Reeves G, Jaffe H, Uganda Kaposi's Sarcoma Study Group: A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. IntJ Cancer 92(5):622-7. 2001 Jun I;
33. Mbidde EK, Banura C, Kazura J, Desmond-Hellmann SD, Kizito A, Hellmann N: NHL and HIV infection in Uganda. 5th International Conference in Africa on AIDS 1990.
34. Lazzi S, Ferrari F, Nyongo A, et al.: HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pothol 1998, 29:1285-1289.
35. Sinfield RL, Molyneux EM, Banda K, Borgstein E, Broadhead R, Hesseling P, Newton R, Casabonne D, Mkandawire N, Nkume H, Hodgson T, Liomba G: Spectrum and presentation of pediatric malignancies in the HIV era: Experience from Blantyre, Malawi, 1998-2003. Pediatric Blood Cancer [http://www3.inter science.wiley.com/cgi-bin]. 2006 Jun 22;
36. Lucas SB, Diomande M, Hounnou A, et al.: HIV-associated lymphoma in Africa: an autopsy study in Côte d'Ivoire. Int J Cancer 1994, 59:20-24.
37. Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katongole-Mbidde E, Wabinga H, Ziegler J: Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS 14(18):2929-36. 2000 Dec 22;
38. Hoang BX, Levine SA, Pham P, Shaw DG: Hypothesis of the cause and development of neoplasms. Eur J Cancer Prev 2007, 16(1):55-61.
39. Besson C, Raphael M: Lymphoma genesis in the context of HIV infection. Ann Med Interne (Paris) 2003, 154(8):523-8.
40. Good RA, Fernandes G, Yunis EJ, Cooper WC, Jose DC, Kramer TR, Hansen MA: Nutritional deficiency, immunologic function, and disease. Am J Pathol 1976, 84(3):599-614.
41. Good RA, West A, Fernandes G: Nutritional modulation of immune responses. Fed Proc 1980, 39(13):3098-104.
42. McMurray DN: Cell-mediated immunity in nutritional deficiency. Prog Food Nutr Sci 1984, 8(3-4):193-228.
43. Good RA, Lorenz E: Nutrition and cellular immunity. Int J Immunopharmacol 1992, 14(3):361-6.